Lemonade, Inc. 8-K

What Happened
Lemonade, Inc. announced on June 24, 2026 (agreement dated June 22, 2026) that it entered a New Business Financing Agreement with Hannover Re (Ireland) DAC. Under the deal Hannover will provide financing to support Lemonade’s sales and marketing Growth Spend from January 1, 2027 through December 31, 2028, with up to $150 million outstanding through 2027 and up to $250 million outstanding during 2028. The company reported this event under Item 1.01 (material definitive agreement) and Item 2.03 (creation of a direct financial obligation) in the 8‑K.

Key Details

• Funding window: January 1, 2027 – December 31, 2028; max outstanding $150M through 12/31/2027 and up to $250M in 2028.
• Per-period financing: At the start of each monthly Growth Period Hannover may fund up to 80% of Growth Spend, not to exceed $20M per Reference Cohort.
• Repayment: Lemonade will repay financed amounts from a defined share of premiums collected for the funded customer cohorts ("Reference Premium"), including the funded amount plus a return equal to the Counterparty Cap Amount (greater of 0% or the 3‑year U.S. Treasury rate, plus 5.8%). Once repaid, Lemonade retains future Reference Premium from that cohort.
• Agreement includes customary representations, financial covenants, cancellation and termination provisions; full agreement expected as an exhibit to Lemonade’s Form 10‑Q for the quarter ended June 30, 2026.

Why It Matters
This is a non‑equity financing arrangement that provides Lemonade with callable capital earmarked for customer acquisition and marketing—potentially accelerating growth without issuing stock. However, it creates a contractual repayment obligation tied to future premiums from specific customer cohorts, which will affect future cash flows until each funded cohort’s obligation is repaid. Investors should review the upcoming 10‑Q exhibit for full terms and monitor how funded Growth Spend, cohort performance and premium collections affect Lemonade’s liquidity and insurance economics.